Methodology for Clinical Trials Involving Patients with Cancer Who Have Febrile Neutropenia: Updated Guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with Emphasis on Outpatient Studies
Authors:
Open Access
- 15 December 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (12) , 1463-1468
Abstract
Two multinational organizations, the Immunocompromised Host Society and the Multinational Association for Supportive Care in Cancer, have produced foKeywords
This publication has 17 references indexed in Scilit:
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999
- Fever and Neutropenia — How to Use a New Treatment StrategyNew England Journal of Medicine, 1999
- A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer ChemotherapyNew England Journal of Medicine, 1999
- Methodology for clinical trials in cancer patients with febrile neutropeniaSupportive Care in Cancer, 1998
- An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsEuropean Journal of Cancer, 1995
- Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic PatientsClinical Infectious Diseases, 1992
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990
- Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.Journal of Clinical Oncology, 1986
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981